4//SEC Filing
Saadi Ryan H. 4
Accession 0001062993-25-011293
CIK 0001860871other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 7:13 PM ET
Size
5.8 KB
Accession
0001062993-25-011293
Insider Transaction Report
Form 4
Saadi Ryan H.
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2025-06-09$1.23/sh−1,438,206$1,768,993→ 116,814,453.322 total
Holdings
- 193,924(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 to $1.425, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Issuer
Tevogen Bio Holdings Inc.
CIK 0001860871
Entity typeother
Related Parties
1- filerCIK 0002011728
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 7:13 PM ET
- Size
- 5.8 KB